Saturday, September 23, 2023
Saturday, September 23, 2023

SODAQ and Nordic Complete a Successful Pilot with a Covid-19 Corona Vaccine Temperature Tracker

November 26, 2020

SODAQ completed 50 successful runs tracking the location and temperature threshold of vaccine shipment containers from va-Q-tec by using the Nordic Semiconductor NRF91 communication module.

SODAQ notes these containers are going to be used for sending Covid-19 vaccines across the world. The vaccines need to be stored in a controlled environment between 2 and 8 degrees Celsius for at least 96 hours during transportation. “The pharmaceutical industry is estimated to incur $15 billion in product losses each year due to temperature deviations alone. Approximately 1.5 percent of all pharmaceutical shipments are marked as scrap due to logistical failures.” according to FedEx.

SODAQ is known for the development of the ultra-low-power and ultra-thin tracking smart label. This solution uses a printed battery and besides location, it senses impact, acceleration, temperature, and the opening of a box. The solution SODAQ designed for the vaccines comes with a rechargeable standard lithium battery. That battery, 6mm thick, is actually the thickest component of the entire device. All other components such as the Nordic nRF9160 chip, the temperature sensor, USB recharge connector and the antenna are all slimmer enabling the device to be inserted into the double-sided cardboard layer of the transportation box.

The test run involved fifty single shipments. Not all these runs were with va-Q-tec boxes. All runs performed exactly as intended, something that does not occur often in proof of concepts using prototypes. The test included the recharging of the device, reusing the device on the same box, and reusing the device on a new box and shipments to various European countries such as Italy, Poland, Germany, the UK, France, and Spain and in addition the US and Canada. In all countries either LTE-M and otherwise NB-IoT connected properly and correctly to the device.

The global connectivity for the pilot was provided via APIs from monogoto, the innovative IoT Connectivity company which provides Infrastructure as a Service (IaaS) for secure cellular connectivity. The monogoto connectivity solution includes a self-service management platform and over 400 APIs, for flexible product prototyping and production IoT networks. Programmed to only send data when in rest, the solution can be moved onto airplanes. The solution from SODAQ and Nordic can also handle different types of cooling boxes using liquid nitrogen or dry ice by applying a different temperature sensor (range: -80 to -20 Celsius).

Attaching a traditional tracker to the outside of a box makes it impossible to stack the boxes and makes the sensor vulnerable. Inserting a device into the box itself is out of the question, the water and aluminum foil keeping the box cool, block every signal from within the box. SODAQ solved this by inserting an external temperature sensor into the box and making the sensor so flat it can be stuck between the cardboard or cover of the box.

The device will cost approximately €27,50 when produced at over 100,000 units, whereas alternatives cost 3 to 4 times as much or are based on less effective solutions such as beacons, RFID, or Bluetooth. None of these work in all the different environments to which the vaccines will be shipped.

SODAQ is actively acquiring customers for the production version of the device.

SourceSODAQ
Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

FDA Grants Fast Track Designation to 9MW3011

9MW3011 has been approved to clinical study by NMPA and FDA, respectively. The first person has been dosed in the clinical study in China in March, 2023.

MicuRx receives FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation for Contezolid and Contezolid acefosamil

"We are pleased to gain the QIDP and Fast Track designations for DFI as recognition that contezolid and contezolid acefosamil are novel new agents to meet an important unmet need in this common and challenging infection", stated Dr Zhengyu Yuan, Chief Executive Officer at MicuRx. 

Via Nova Therapeutics Announces FDA clearance of Investigational New Drug (IND) Application for VNT-101

"We look forward to evaluating VNT-101 in the clinic," said Don Ganem MD, Co-Founder and CEO of Via Nova Therapeutics. "This is an important step to developing a flu antiviral with a novel mechanism of action, and a milestone for Via Nova Therapeutics as we advance our first compound into the clinic."

FDA OK’s ensoETM for Use in Cardiac Ablations to Reduce Risk of Esophageal Injury

Published studies that have examined the use of ensoETM for this purpose include the pilot eCOOL-AF study, the IMPACT study and a large multi-center analysis of over 25,000 patients (in press at the Journal of the American College of Cardiology: Clinical Electrophysiology). These studies have found up to an 83 percent reduction in esophageal injuries, and a significant reduction in risk of atrioesophageal fistula (AEF), one of the most dreaded complications of ablation procedures.

Annalise.ai Receives FDA Clearance and Breakthrough Device Designation

Annalise.ai has also received FDA Breakthrough Device Designation for its obstructive hydrocephalus software tool. This is the first radiology triage device to be granted Breakthrough status since the inception of the FDA Breakthrough Devices Program.

By using this website you agree to accept Medical Device News Magazine Privacy Policy